Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has been updated to Revision: v3.0.2, replacing v3.0.1, indicating an update to the content. The Back to Top element was removed, a minor UI change.
    Difference
    0.4%
    Check dated 2025-09-14T00:17:48.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.4%
    Check dated 2025-09-06T21:13:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as detailed drug information related to Ruxolitinib and various blood disorders. Several previous entries have been removed, particularly related to specific locations and diseases.
    Difference
    25%
    Check dated 2025-08-30T15:35:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.3%
    Check dated 2025-08-23T14:10:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.8%
    Check dated 2025-08-16T12:09:58.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.9%
    Check dated 2025-08-09T07:46:31.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.